Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Betamarc is effective in improving the
appetite and reversing weight loss in patients with advanced Non-Small Cell Lung Cancer.